Amigo AI
Amigo AI58
About
What does Amigo AI do?
Amigo AI offers a trusted platform for building, training, and deploying clinical agents designed to augment healthcare teams. Their solution enables organizations to create custom AI agents for specific patient needs and workflows, increasing clinical capacity while adhering to healthcare safety and reliability standards. Amigo AI serves healthcare leaders worldwide across various specialties, including primary care, digital health, and cancer care.
What is Amigo AI's revenue?
StartupHub estimates Amigo AI's annual revenue at $9.1M (range $4.9M to $17.5M, 66% confidence), based on comparable companies in the sector.
What is Amigo AI's valuation?
StartupHub estimates Amigo AI's effective valuation at $1.1B (range $756.5M to $1.4B, 41% confidence), based on comparable companies in the sector.
How much funding has Amigo AI raised?
Amigo AI has raised a total of $17M in funding. The most recent round on record is Series A.
Where is Amigo AI headquartered?
Amigo AI is headquartered in New York, United States.
When was Amigo AI founded?
Amigo AI was founded in 2022.
What industry does Amigo AI operate in?
Amigo AI operates in Artificial Intelligence, Healthcare, Biotechnology, Machine Learning, AI, HealthTech.
How many employees does Amigo AI have?
Amigo AI has approximately 60 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.